De Scheerder Pharmaceuticals SRL
De Scheerder Pharmaceuticals reported total assets of 71,702 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jan 2026).
The score of De Scheerder Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +508 % Total assets +366 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Scheerder Pharmaceuticals's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 17 Jan 2026
- Year ended 30 Jun 2024filed on 17 Jan 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 29 Jan 2023
- Year ended 30 Jun 2021filed on 20 Dec 2021
De Scheerder Pharmaceuticals's financial analysis
- Solvency95.4%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Scheerder Pharmaceuticals
De Scheerder Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0752.564.602
- VAT number
- BE0752564602
- Peppol
- Registered · 0208:0752564602 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Aug 2020
- Registered office
- 9030 Ghent
- Latest accounts
- 2025 · filed on 17 Jan 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
De Scheerder Pharmaceuticals (SRL) has been based in Ghent since 2020, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 25,124 € and equity of 68,424 €; its revenue is not published. Its solvency stands at 95.4%, above the median of its sector (55.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Scheerder Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Jens Consulting Other business support service activities n.e.c. Ghent · balance sheet 70,335 €
- Noble Hospitality Other business support service activities n.e.c. Antwerp · balance sheet 71,576 €
- Alrasol Energy Other business support service activities n.e.c. Genk · balance sheet 71,974 €
- Arvos Consulting Other business support service activities n.e.c. Temse · balance sheet 72,263 €
- Macam Other business support service activities n.e.c. Brussels · balance sheet 72,284 €
- Uyttebroek-Andries Other business support service activities n.e.c. Herentals · balance sheet 71,032 €
- Casa in Other business support service activities n.e.c. Ixelles · balance sheet 72,626 €
- Mivan Other business support service activities n.e.c. Ostend · balance sheet 72,632 €
Frequently asked questions about De Scheerder Pharmaceuticals
What is the revenue of De Scheerder Pharmaceuticals?
De Scheerder Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Scheerder Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0752564602 for De Scheerder Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0752.564.602.
Where is the registered office of De Scheerder Pharmaceuticals?
According to the CBE register, the registered office of De Scheerder Pharmaceuticals is in 9030 Ghent.
What is the equity of De Scheerder Pharmaceuticals?
At the close of the 2025 financial year, the equity of De Scheerder Pharmaceuticals amounts to 68,424 €, a solvency of 95.4% of total assets.
Who manages De Scheerder Pharmaceuticals?
The register lists 1 active mandates at De Scheerder Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Scheerder Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →